V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010950 | 280004715 | 1.54 | 67.05 | Palliative (P) | 2018-07-31 | 2018-08-19 | Trabectedin | 2 | null | 280024617 | TRABECTEDIN |
| 280010951 | 280004719 | 1.65 | 60 | Curative (C) | 2015-12-12 | 2016-08-21 | Cisplatin + Radiotherapy | N | Y | 280024622 | CISPLATIN + RT |
| 280010952 | 280004721 | 1.65 | 78.8 | Palliative (P) | 2018-01-27 | 2018-01-27 | Trial Unspecified | N | N | 280024637 | TRIAL |
| 280010953 | 280010307 | 1.68 | 75.2 | Palliative (P) | 2015-10-29 | 2015-12-14 | Trabectedin | N | Y | 280024657 | TRABECTEDIN |
| 280010954 | 280004728 | 1.68 | 69.7 | Adjuvant (A) | 2015-03-20 | 2015-04-11 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 280024659 | CISPLATIN + RT |
| 280010955 | 280004738 | 1.76 | null | 2 | 2013-10-10 | 2013-10-25 | Cisplatin 100 + RT(H&N) 1 day | null | null | 280024703 | CISPLATIN + RT |
| 280010956 | 280004740 | 1.56 | 82 | Curative (C) | 2014-08-06 | 2016-09-04 | CISPLATIN + RT | Y | null | 280024714 | CISPLATIN + RT |
| 280010957 | 280004749 | 1.66 | 73.3 | null | 2015-05-28 | 2015-06-11 | EW EuroEwing 2012 Arm A VAI | Y | N | 280024740 | TRIAL |
| 280010958 | 280004755 | null | 48.4 | Curative (C) | null | 2016-10-01 | Cisplatin 100 + RT(H&N) 1 day | N | N | 280024744 | CISPLATIN + RT |
| 280010959 | 280011203 | 1.75 | 97.5 | Curative (C) | 2015-06-24 | 2015-07-26 | Cisplatin + Radiotherapy | N | N | 280024746 | CISPLATIN + RT |
| 280010960 | 280004757 | 1.66 | 71.4 | Neo-adjuvant (N) | 2013-06-16 | 2013-08-16 | EW EuroEwing 2012 Arm B IE | Y | Y | 280024748 | TRIAL |
| 280010961 | 280004759 | 1.79 | 97 | Curative (C) | 2013-10-04 | 2013-10-08 | Cisplatin 100 + RT(H&N) 1 day | N | null | 280024762 | CISPLATIN + RT |
| 280010962 | 280004760 | 1.56 | 48.4 | Curative (C) | 2015-02-20 | 2015-02-21 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 280024764 | CISPLATIN + RT |
| 280010963 | 280011206 | 1.77 | null | null | 2015-06-05 | 2015-06-26 | EW EuroEwing 2012 Arm A VAI | N | N | 280024776 | TRIAL |
| 280010964 | 280004766 | 1.77 | 100.1 | Curative (C) | 2016-07-20 | 2016-07-20 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 280024777 | CISPLATIN + RT |
| 280010965 | 280004767 | null | 54.2 | Adjuvant (A) | 2015-12-21 | 2015-12-24 | CISPLATIN + RT | N | N | 280024778 | CISPLATIN + RT |
| 280010966 | 280011654 | 1.72 | 86.95 | null | null | 2016-06-17 | Trabectedin | N | null | 280024787 | TRABECTEDIN |
| 280010967 | 280004772 | 1.69 | 103 | Curative (C) | 2017-06-20 | 2017-07-07 | CISPLATIN + RT | N | null | 280024798 | CISPLATIN + RT |
| 280010968 | 280008539 | 1.58 | null | null | 2016-02-17 | 2016-02-29 | Trabectedin | 02 | N | 280024802 | TRABECTEDIN |
| 280010969 | 280004776 | 1.8 | 84.4 | Not known (9) | 2014-01-23 | 2014-02-02 | Cisplatin 100 + RT(H&N) 1 day | N | N | 280024803 | CISPLATIN + RT |
| 280010970 | 280004779 | null | 89.4 | Adjuvant (A) | 2017-07-20 | 2017-07-20 | Cisplatin 100 + RT(H&N) 1 day | N | null | 280024804 | CISPLATIN + RT |
| 280010971 | 280004785 | 1.83 | 76 | Curative (C) | 2016-09-09 | 2017-02-01 | EW EuroEwing 2012 Arm B VDC | N | N | 280024821 | TRIAL |
| 280010972 | 280004794 | 1.72 | 68.8 | Neo-adjuvant (N) | 2018-04-17 | 2018-04-25 | Cisplatin 100 + RT(H&N) 1 day | N | null | 280024836 | CISPLATIN + RT |
| 280010973 | 280004797 | 1.75 | 77 | Palliative (P) | 2016-04-17 | 2016-06-16 | LUX TRIAL | N | Y | 280024851 | TRIAL |
| 280010974 | 280004804 | null | 77.2 | Curative (C) | 2016-08-25 | 2016-08-25 | Cisplatin + Radiotherapy | N | N | 280024866 | CISPLATIN + RT |
| 280010975 | 280004814 | null | 77.6 | Curative (C) | null | 2014-04-30 | Cisplatin + Radiotherapy | 02 | N | 280024885 | CISPLATIN + RT |
| 280010976 | 280004816 | 1.81 | null | Curative (C) | 2017-01-30 | 2017-02-20 | Cisplatin 100 + RT(H&N) 1 day | N | null | 280024886 | CISPLATIN + RT |
| 280010977 | 280011212 | null | null | Palliative (P) | 2017-08-20 | 2017-09-13 | Cetuximab 7 day (Cycle 1) | N | null | 280024889 | CETUXIMAB |
| 280010978 | 280012100 | 0 | 80.5 | Adjuvant (A) | 2016-03-10 | 2016-08-10 | NB HRNBL-1 COJEC Ind COURSE C | N | N | 280024894 | NOT MATCHED |
| 280010979 | 280008555 | null | 63 | Palliative (P) | 2018-03-24 | 2018-05-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280024896 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010980 | 280004825 | 1.7 | 112 | Palliative (P) | 2014-05-23 | 2014-06-06 | Cetuximab 14 day | Y | N | 280024897 | CETUXIMAB |
| 280010981 | 280004827 | null | 55.2 | Curative (C) | 2016-04-28 | 2016-04-29 | Carboplatin AUC 6 - 10 | Y | N | 280024903 | CARBOPLATIN |
| 280010982 | 280004830 | 1.62 | 54.7 | Neo-adjuvant (N) | 2017-03-03 | 2017-05-11 | Carboplatin AUC 2 - 5 | N | Y | 280024914 | CARBOPLATIN |
| 280010983 | 280004835 | 0 | null | Palliative (P) | 2017-10-09 | 2017-11-02 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | N | 280024922 | NOT MATCHED |
| 280010984 | 280004837 | 1.79 | 8.4 | Palliative (P) | 2015-10-04 | 2015-10-04 | Docetaxel + Gemcitabine with GCSF | N | N | 280024927 | DOCETAXEL + GEMCITABINE |
| 280010985 | 280004845 | 1.63 | null | Palliative (P) | 2015-11-02 | 2015-12-12 | Carboplatin AUC 2 - 5 | N | N | 280024930 | CARBOPLATIN |
| 280010986 | 280004852 | 1.7 | 55.6 | Curative (C) | 2014-09-23 | 2014-11-26 | Carboplatin AUC 2 - 5 | N | null | 280024949 | CARBOPLATIN |
| 280010987 | 280004855 | null | null | Palliative (P) | 2016-08-11 | 2016-10-02 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024952 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010988 | 280004857 | 1.7 | 67 | Curative (C) | null | 2013-07-31 | Carboplatin AUC 6 - 10 | N | N | 280024952 | CARBOPLATIN |
| 280010989 | 280004860 | 1.74 | 4.6 | Neo-adjuvant (N) | 2014-09-28 | 2015-08-01 | DOCETAXEL + GEMCITABINE | N | null | 280024955 | DOCETAXEL + GEMCITABINE |
| 280010990 | 280008577 | 1.7 | 79.8 | Palliative (P) | null | 2014-05-17 | CETUXIMAB | N | N | 280024968 | CETUXIMAB |
| 280010991 | 280004868 | 1.68 | 62.7 | Palliative (P) | 2016-04-12 | 2016-04-17 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | 280024984 | DOCETAXEL + GEMCITABINE |
| 280010992 | 280004871 | 1.63 | 87.7 | Palliative (P) | 2017-04-10 | 2017-05-07 | CETUXIMAB | 02 | N | 280024990 | CETUXIMAB |
| 280010993 | 280011219 | 1.6 | null | Curative (C) | 2017-08-28 | 2017-10-20 | CARBOPLATIN | N | N | 280025005 | CARBOPLATIN |
| 280010994 | 280004877 | 1.78 | 75.5 | Curative (C) | 2016-07-15 | 2016-01-18 | Cetuximab 7 day (>Cycle 2) | 02 | N | 280025015 | CETUXIMAB |
| 280010995 | 280004882 | null | null | Palliative (P) | 2016-02-18 | 2016-02-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025025 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010996 | 280004886 | 0 | 72 | Disease modification (D) | 2016-10-02 | 2016-10-02 | AML Interim Guidelines | null | N | 280025034 | NOT MATCHED |
| 280010997 | 280004888 | 1.69 | null | Adjuvant (A) | 2014-07-05 | 2014-07-27 | DOCETAXEL + GEMCITABINE | null | Y | 280025036 | DOCETAXEL + GEMCITABINE |
| 280010998 | 280004891 | null | null | Curative (C) | 2016-05-31 | 2016-06-20 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 280025037 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010999 | 280004892 | 0 | 30 | Neo-adjuvant (N) | 2014-08-19 | 2014-09-05 | NB HRNBL-1 Isotretinoin | 2 | null | 280025039 | NOT MATCHED |